calendar
7,525 catalysts · 3,350 8k filing · 1,096 grant · 1,000 device adverse event · 580 earnings · 550 approval · 430 device 510k
7,525 catalysts · 3,350 8k filing · 1,096 grant · 1,000 device adverse event · 580 earnings · 550 approval · 430 device 510k
HL grant. $1,137,435. PI: Kiran Musunuru
CA grant. $1,053,426. PI: Danielle Friedman
AG grant. $746,160. PI: Emilia Favuzzi
DK grant. $821,916. PI: SUSAN MARIE WALL
NR grant. $732,795. PI: Mucio Delgado
TR grant. $3,516,688. PI: April Marie Craft
CA grant. $667,710. PI: Aadel Chaudhuri
DK grant. $782,361. PI: Kendra Joy Kamp
CA grant. $975,000. PI: Missak Haigentz
NS grant. $487,858. PI: Luka Milosevic
Sponsor: PH HEALTH. Form: INJECTABLE. Route: INJECTION
Sponsor: RISING. Form: SOLUTION. Route: TOPICAL
Sponsor: AUROBINDO PHARMA LTD. Form: CAPSULE. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: STRIDES PHARMA. Form: TABLET. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: CAPSULE. Route: ORAL
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
Product code: PMN. Advisory committee: Microbiology. Type: Traditional
Product code: KTT. Advisory committee: Orthopedic. Type: Traditional
Product code: JAK. Advisory committee: Radiology. Type: Traditional
Product code: JAK. Advisory committee: Radiology. Type: Traditional
Product code: DZE. Advisory committee: Dental. Type: Traditional
Product code: OHS. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: GAT. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: HRS. Advisory committee: Orthopedic. Type: Abbreviated
Supplement type: Normal 180 Day Track No User Fee. Product code: POH. Advisory committee: NE. Decision: APPR
Supplement type: 30-Day Notice. Product code: MJO. Advisory committee: OR. Decision: OK30
Supplement type: 30-Day Notice. Product code: NIP. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: QAN. Advisory committee: CV. Decision: OK30
Supplement type: Normal 180 Day Track. Product code: QZI. Advisory committee: CV. Decision: APPR
Supplement type: 30-Day Notice. Product code: MJO. Advisory committee: OR. Decision: OK30
Supplement type: 30-Day Notice. Product code: NIM. Advisory committee: CV. Decision: OK30
TR grant. $30,000. PI: Matthew H Porteus
NR grant. $430,884. PI: Carolyn Phillips
GM grant. $417,061. PI: Christopher J Easley
CA grant. $694,122. PI: Naykky Singh Ospina
CA grant. $8,000. PI: DAVID J. STEWART
Sponsor: UNIQUE PHARM. Form: TABLET. Route: ORAL
Sponsor: ASCENT PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: ZHEJIANG JINGXIN. Form: TABLET. Route: ORAL
Sponsor: DENALI THERAPEUTICS INC.. Form: INJECTION. Route: POWDER,FOR SOLUTION
Sponsor: KENVUE BRANDS. Form: TABLET, CHEWABLE. Route: ORAL
Sponsor: ALVOGEN. Form: CAPSULE. Route: ORAL
Sponsor: ALVOGEN. Form: CAPSULE. Route: ORAL
Sponsor: ALVOGEN. Form: CAPSULE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: FOR SUSPENSION. Route: ORAL
Sponsor: OTSUKA ICU MEDCL. Form: INJECTABLE. Route: INJECTION
Product code: MUE. Advisory committee: Radiology. Type: Traditional
Product code: OAB. Advisory committee: General, Plastic Surgery. Type: Traditional